• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,802.90 -607.08
( -0.78%)
Global Indices
Nasdaq
51,585.70 72.15
(0.14%)
Dow Jones
7,521.58 80.48
(1.08%)
Hang Seng
70,971.12 -82.37
(-0.12%)
Nikkei 225
10,357.71 -41.99
(-0.40%)
Forex
USD-INR
94.39 -0.12
(-0.13%)
EUR-INR
108.40 -1.03
(-0.94%)
GBP-INR
125.08 -1.43
(-1.13%)
JPY-INR
0.59 0.00
(-0.50%)

EQUITY - MARKET SCREENER

Alpa Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532878
INE385I01010
93.4291798
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ALPA
9.55
142.82
EPS(TTM)
Face Value()
Div & Yield %
7.11
10
0
 

Can Fin Homes standalone net profit rises 47.77% in the March 2026 quarter
Apr 25,2026
Net profit of Can Fin Homes rose 47.77% to Rs 345.67 crore in the quarter ended March 2026 as against Rs 233.92 crore during the previous quarter ended March 2025. Sales rose 7.52% to Rs 1073.65 crore in the quarter ended March 2026 as against Rs 998.58 crore during the previous quarter ended March 2025.

For the full year,net profit rose 26.67% to Rs 1085.75 crore in the year ended March 2026 as against Rs 857.17 crore during the previous year ended March 2025. Sales rose 8.70% to Rs 4216.27 crore in the year ended March 2026 as against Rs 3878.64 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1073.65998.58 8 4216.273878.64 9
OPM %92.2591.79 -92.0692.24 -
PBDT357.90283.28 26 1320.261090.35 21
PBT352.98279.16 26 1303.571077.48 21
NP345.67233.92 48 1085.75857.17 27